/People

Nanna Lüneborg

Investor

General Partner at Forbion

Amsterdam Area

Writes $100K – $5M checks · typically $1.5M

Find your path to Nanna

Sign up to see every warm intro you have to Nanna

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Nanna. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

General Partner at Forbion, holds a PhD and MBA.

Deals · 1

MapLight TherapeuticsBoard seat

via Forbion · filed Jul 2025 · $372.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at Forbion

Network1

Investors connected to Nanna in public investor directories — a warm-intro map.

Frequently asked questions

Who is Nanna Lüneborg?
General Partner at Forbion, holds a PhD and MBA.
Where does Nanna Lüneborg work?
Nanna Lüneborg is General Partner at Forbion.
What check size does Nanna Lüneborg write?
Nanna Lüneborg typically writes checks of $100K – $5M.
What boards does Nanna Lüneborg sit on?
Nanna Lüneborg holds tracked board seats at Capstan Therapeutics, MapLight Therapeutics.
What companies has Nanna Lüneborg invested in?
Investments tracked here include Capstan Therapeutics, F2G, Inthera Bioscience, Inversago, LAVA Therapeutics, MapLight Therapeutics, NBE-Therapeutics, Noema Pharma, Numab, Rezera, Sparrow Pharma.

About this profile. Compiled from public sources — Forbion's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights